One-year data from a large real-world dataset provide reassurance that clinical outcomes with the new-generation LAA occlusion device for stroke prevention compare well with those from pivotal trials.
SURPASS Study Confirms Real-World Safety and Efficacy of Watchman FLX Through 45 Days
Interim data from a large real-world dataset provide reassurance about acute and subacute procedural outcomes with the new-generation LAA occlusion device for stroke prevention.
Launching an LAAO Program: How Cleveland Clinic Assisted an Affiliated Institution
This case study details how a Missouri medical center quickly turned a site visit to Cleveland Clinic into a full-fledged program for left atrial appendage occlusion, with 25 procedures done within the first year.